Variant report

Variant	esv3359531
Chromosome Location	chr22:27706552-27710850
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:92)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:92 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr22:27710264-27710774	K562	blood:	n/a	n/a
2	ATF1	chr22:27710224-27710722	K562	blood:	n/a	n/a
3	ATF3	chr22:27710336-27710686	K562	blood:	n/a	n/a
4	ATF3	chr22:27710397-27710612	K562	blood:	n/a	n/a
5	BCL3	chr22:27708636-27708941	GM12878	blood:	n/a	n/a
6	BHLHE40	chr22:27708785-27708985	K562	blood:	n/a	n/a
7	BHLHE40	chr22:27710270-27710774	K562	blood:	n/a	n/a
8	CCNT2	chr22:27710133-27710825	K562	blood:	n/a	n/a
9	CEBPB	chr22:27710237-27710842	K562	blood:	n/a	n/a
10	CEBPB	chr22:27710302-27710793	K562	blood:	n/a	n/a
11	CEBPD	chr22:27710203-27710835	K562	blood:	n/a	n/a
12	CEBPD	chr22:27710245-27710801	K562	blood:	n/a	n/a
13	CTBP2	chr22:27706842-27708052	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr22:27707760-27707910	HBMEC	blood vessel:	n/a	n/a
15	CTCF	chr22:27707700-27707850	HUVEC	blood vessel:	n/a	n/a
16	CTCF	chr22:27708664-27708804	GM19239	blood:	n/a	n/a
17	CUX1	chr22:27710344-27710713	K562	blood:	n/a	n/a
18	E2F6	chr22:27707230-27707788	H1-hESC	embryonic stem cell:	n/a	n/a
19	E2F6	chr22:27707076-27708048	H1-hESC	embryonic stem cell:	n/a	n/a
20	EP300	chr22:27710239-27710853	K562	blood:	n/a	n/a
21	EP300	chr22:27710325-27710723	K562	blood:	n/a	n/a
22	GABPA	chr22:27710263-27710828	K562	blood:	n/a	n/a
23	GATA1	chr22:27709979-27711251	K562	blood:	n/a	n/a
24	GATA1	chr22:27709823-27710863	PBDE	blood:	n/a	n/a
25	GATA2	chr22:27710153-27710871	K562	blood:	n/a	n/a
26	GATA2	chr22:27710281-27710792	K562	blood:	n/a	n/a
27	GATA2	chr22:27710284-27710814	K562	blood:	n/a	n/a
28	HMGN3	chr22:27710329-27710789	K562	blood:	n/a	n/a
29	IRF1	chr22:27710302-27710764	K562	blood:	n/a	n/a
30	JUN	chr22:27710296-27710686	K562	blood:	n/a	n/a
31	JUN	chr22:27710170-27710798	K562	blood:	n/a	n/a
32	JUN	chr22:27710318-27710632	K562	blood:	n/a	n/a
33	JUN	chr22:27710301-27710723	K562	blood:	n/a	n/a
34	JUND	chr22:27710239-27710828	K562	blood:	n/a	n/a
35	JUND	chr22:27710367-27710650	HepG2	liver:	n/a	n/a
36	KAP1	chr22:27709984-27710997	HEK293	kidney:	n/a	n/a
37	MAFK	chr22:27710348-27710528	K562	blood:	n/a	n/a
38	MAX	chr22:27710359-27710777	K562	blood:	n/a	n/a
39	MAX	chr22:27707373-27707955	H1-hESC	embryonic stem cell:	n/a	n/a
40	MAX	chr22:27707275-27707944	H1-hESC	embryonic stem cell:	n/a	n/a
41	MAX	chr22:27707271-27707953	H1-hESC	embryonic stem cell:	n/a	n/a
42	MAZ	chr22:27710249-27710752	K562	blood:	n/a	n/a
43	MXI1	chr22:27707489-27708099	H1-hESC	embryonic stem cell:	n/a	n/a
44	MYC	chr22:27710285-27710837	K562	blood:	n/a	n/a
45	MYC	chr22:27707479-27707819	H1-hESC	embryonic stem cell:	n/a	n/a
46	MYC	chr22:27710318-27710700	K562	blood:	n/a	n/a
47	MYC	chr22:27710347-27710663	K562	blood:	n/a	n/a
48	MYC	chr22:27708663-27708710	MCF-7	breast:	n/a	n/a
49	MYC	chr22:27708832-27708861	MCF-7	breast:	n/a	n/a
50	MYC	chr22:27708821-27708839	MCF-7	breast:	n/a	n/a

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr22:27707736..27710195-chr22:27719270..27720776,2	MCF-7	breast:
2	chr22:27700594..27703155-chr22:27710130..27712224,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CRYBA4-8	chr22:27710722-27711008	XLOC_014197
2	lnc-CRYBA4-8	chr22:27706612-27711010	XLOC_014197
3	lnc-CRYBA4-8	chr22:27706612-27711010	ENSG00000226741

No data

Variant related genes	Relation type
ENSG00000226741	TF binding region
PAIP2	miRNA target sites

Extended variants
information (count: 194 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:194 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563257911	chr22:27706558-27706559	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs530718298	chr22:27706561-27706562	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs552432247	chr22:27706581-27706582	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs572428918	chr22:27706594-27706595	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs66882177	chr22:27706608-27706609	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs143113122	chr22:27706745-27706746	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
7	rs73430470	chr22:27706816-27706817	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs566032292	chr22:27706827-27706828	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
9	rs116699300	chr22:27706878-27706879	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs555031305	chr22:27706914-27706915	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs6005370	chr22:27706941-27706942	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs531937970	chr22:27706954-27706955	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs115568136	chr22:27706970-27706971	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs558764690	chr22:27706976-27706977	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs186883990	chr22:27706987-27706988	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
16	rs147495098	chr22:27707003-27707004	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
17	rs538238768	chr22:27707005-27707006	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
18	rs553270559	chr22:27707057-27707058	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
19	rs192107968	chr22:27707077-27707078	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs111874954	chr22:27707087-27707088	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
21	rs572541026	chr22:27707098-27707099	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
22	rs116042699	chr22:27707114-27707115	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
23	rs35575363	chr22:27707131-27707132	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs530569551	chr22:27707140-27707141	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
25	rs184318706	chr22:27707147-27707148	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
26	rs367721061	chr22:27707159-27707160	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
27	rs564233632	chr22:27707167-27707168	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
28	rs571788319	chr22:27707193-27707194	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs199628027	chr22:27707209-27707210	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs540762609	chr22:27707228-27707229	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs528298769	chr22:27707260-27707261	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs546881028	chr22:27707273-27707274	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs543131097	chr22:27707288-27707289	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs568297953	chr22:27707310-27707311	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
35	rs530082298	chr22:27707336-27707337	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
36	rs548338893	chr22:27707341-27707342	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
37	rs369033467	chr22:27707360-27707361	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
38	rs534499049	chr22:27707399-27707400	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
39	rs115264455	chr22:27707423-27707424	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs116101203	chr22:27707486-27707487	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs547049678	chr22:27707492-27707493	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs189480069	chr22:27707501-27707502	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs570446016	chr22:27707528-27707529	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
44	rs193068678	chr22:27707532-27707533	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
45	rs5762061	chr22:27707548-27707549	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
46	rs534906124	chr22:27707567-27707568	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
47	rs553239565	chr22:27707590-27707591	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
48	rs575061266	chr22:27707597-27707598	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
49	rs148110658	chr22:27707601-27707602	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
50	rs374051710	chr22:27707619-27707620	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Velocardiofacial syndrome	20111667	CNVD
Medulloblastoma	21979893	CNVD
sporadic solitary meningiomas	19589153	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Congenital heart defect	22511896	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Seminomas	18059402	CNVD
Cancer	16751803	CNVD
Metanephric adenoma	20802469	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Metachromatic leukodystrophy	18421352	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Breast cancer	21858162	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	22174824	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Wilms tumour	21544195	CNVD
Acute myeloid leukemia	21251322	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21785460	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Lung cancer	18438408	CNVD
Pancreatic endocrine tumor	17639061	CNVD
abnormal development	18461090	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Cancer	21183584	CNVD
Breast cancer	17142309	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Cat eye syndrome	16708226	CNVD
Olfactory neuroblastoma	18408657	CNVD
Renal cell carcinoma	18765545	CNVD
Schizophrenia	19521646	CNVD
Schizophrenia	18990708	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Hepatocellular carcinoma	16750200	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:232 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:27703400-27706800	Weak transcription	Fetal Intestine Large	intestine
2	chr22:27703600-27706800	Weak transcription	Rectal Mucosa Donor 31	rectum
3	chr22:27704200-27708600	Weak transcription	Right Atrium	heart
4	chr22:27704600-27707600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr22:27705600-27708400	Enhancers	Fetal Brain Male	brain
6	chr22:27705800-27706800	Enhancers	Fetal Stomach	stomach
7	chr22:27705800-27707800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
8	chr22:27705800-27708400	Enhancers	H9 Cell Line	embryonic stem cell
9	chr22:27705800-27709400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr22:27705800-27710800	Enhancers	Ovary	ovary
11	chr22:27706000-27706600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr22:27706000-27706800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr22:27706000-27706800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr22:27706000-27708400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr22:27706000-27709200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr22:27706000-27709400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
17	chr22:27706000-27709600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr22:27706200-27707000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr22:27706200-27707000	Enhancers	Fetal Brain Female	brain
20	chr22:27706200-27707600	Enhancers	Brain Germinal Matrix	brain
21	chr22:27706200-27708000	Weak transcription	Aorta	Aorta
22	chr22:27706200-27708200	Bivalent Enhancer	Fetal Muscle Leg	muscle
23	chr22:27706600-27708400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr22:27706800-27707000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
25	chr22:27706800-27707000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
26	chr22:27706800-27707000	Enhancers	Brain Anterior Caudate	brain
27	chr22:27706800-27707000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
28	chr22:27706800-27707000	Bivalent Enhancer	Fetal Kidney	kidney
29	chr22:27706800-27707000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
30	chr22:27706800-27707200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr22:27706800-27707200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr22:27706800-27707200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
33	chr22:27706800-27707200	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
34	chr22:27706800-27707600	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
35	chr22:27706800-27707800	Enhancers	HUES48 Cell Line	embryonic stem cell
36	chr22:27706800-27707800	Bivalent Enhancer	Fetal Stomach	stomach
37	chr22:27706800-27707800	Enhancers	Rectal Mucosa Donor 31	rectum
38	chr22:27706800-27708800	Enhancers	Spleen	Spleen
39	chr22:27706800-27709000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr22:27706800-27709000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr22:27706800-27709400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr22:27706800-27715400	Enhancers	Fetal Intestine Large	intestine
43	chr22:27707000-27707200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
44	chr22:27707000-27707400	Weak transcription	Brain Anterior Caudate	brain
45	chr22:27707000-27707600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
46	chr22:27707000-27708000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
47	chr22:27707000-27708200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
48	chr22:27707000-27708400	Flanking Active TSS	Fetal Brain Female	brain
49	chr22:27707000-27708800	Enhancers	Placenta Amnion	Placenta Amnion
50	chr22:27707000-27709400	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links